Get ready for the NCLEX Exam! Practice with our comprehensive quizzes and multiple choice questions. Each question offers detailed explanations to help you understand the material and improve your test-taking skills. Boost your confidence today!

Multiple Choice

What intervention is essential prior to starting a client on atorvastatin therapy?

Monitoring liver function tests is an essential intervention prior to starting a client on atorvastatin therapy. Atorvastatin is a statin used to lower cholesterol levels, and one of its potential side effects is liver damage, which can manifest as elevated liver enzymes. Before initiating treatment, it is important to establish a baseline for liver function tests, as this helps to identify any pre-existing liver issues and allows for monitoring throughout the therapy. If liver enzymes are significantly elevated before starting the medication, this could indicate that the client should not begin atorvastatin or that special precautions must be taken. Regular monitoring during treatment is also necessary to detect any changes that could suggest hepatotoxicity, ensuring the client's safety while on the medication. While assessing dietary intake can provide valuable information regarding lifestyle and compliance, it does not directly address the key concerns related to atorvastatin's impact on liver function. Other interventions, like assessing for muscle strength or determining concurrent medication use, do not have the same urgency or relevance when starting this specific therapy.

Monitoring liver function tests is an essential intervention prior to starting a client on atorvastatin therapy. Atorvastatin is a statin used to lower cholesterol levels, and one of its potential side effects is liver damage, which can manifest as elevated liver enzymes.

Before initiating treatment, it is important to establish a baseline for liver function tests, as this helps to identify any pre-existing liver issues and allows for monitoring throughout the therapy. If liver enzymes are significantly elevated before starting the medication, this could indicate that the client should not begin atorvastatin or that special precautions must be taken. Regular monitoring during treatment is also necessary to detect any changes that could suggest hepatotoxicity, ensuring the client's safety while on the medication.

While assessing dietary intake can provide valuable information regarding lifestyle and compliance, it does not directly address the key concerns related to atorvastatin's impact on liver function. Other interventions, like assessing for muscle strength or determining concurrent medication use, do not have the same urgency or relevance when starting this specific therapy.